Brevitest

Brevitest is a startup based in Houston, the United States. Its most recent tracked round is Seed. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.

Brevitest develops portable, point-of-care diagnostic devices that perform rapid, quantitative enzyme immunoassays to detect and measure a wide range of biomarkers and substances in blood, enabling faster, cost-effective testing outside traditional labs.